$37M sweet spot round size
Most of their 7 investments are in rounds between $2.3M and $58M
Apexigen raised $65M on March 24, 2020
Investors: Oceanpine Capital, SV Tech Ventures, Decheng Capital, 3E Bioventures Capital and VI Ventures
Undisclosed raised $20M on July 19, 2019
Investors: Efung Capital, Lombard Odier Group and VI Ventures
Apexigen raised $58M on August 8, 2018
Investors: 3E Bioventures Capital, SV Tech Ventures and VI Ventures
Smartzyme Biopharma raised undisclosed on March 14, 2018
Investors: OrbiMed Advisors and VI Ventures
Rani Therapeutics raised $53M on February 7, 2018
Investors: Shire Pharmaceuticals, GV, PingAn Ventures and VI Ventures
Undisclosed raised $2.3M on December 7, 2016
Investors: B. Braun Medical and VI Ventures
Undisclosed raised $1M on October 20, 2015
Investors: VI Ventures